1
|
Serrano M and Massagué J: Networks of
tumor suppressors. Workshop: Tumor suppressor networks. EMBO Rep.
1:115–119. 2000. View Article : Google Scholar : PubMed/NCBI
|
2
|
Nieto MA: The snail superfamily of
zinc-finger transcription factors. Nat Rev Mol Cell Biol.
3:155–166. 2002. View
Article : Google Scholar : PubMed/NCBI
|
3
|
Peinado H, Olmeda D and Cano A: Snail, Zeb
and bHLH factors in tumour progression: An alliance against the
epithelial phenotype? Nat Rev Cancer. 7:415–428. 2007. View Article : Google Scholar : PubMed/NCBI
|
4
|
Uygur B and Wu WS: SLUG promotes prostate
cancer cell migration and invasion via CXCR4/CXCL12 axis. Mol
Cancer. 10:1392011. View Article : Google Scholar : PubMed/NCBI
|
5
|
Castro Alves C, Rosivatz E, Schott C,
Hollweck R, Becker I, Sarbia M, Carneiro F and Becker KF: Slug is
overexpressed in gastric carcinomas and may act synergistically
with SIP1 and snail in the down-regulation of E-cadherin. J Pathol.
211:507–515. 2007. View Article : Google Scholar : PubMed/NCBI
|
6
|
Uchikado Y, Natsugoe S, Okumura H,
Setoyama T, Matsumoto M, Ishigami S and Aikou T: Slug Expression in
the E-cadherin preserved tumors is related to prognosis in patients
with esophageal squamous cell carcinoma. Clin Cancer Res.
11:1174–1180. 2005.PubMed/NCBI
|
7
|
Alves CC, Carneiro F, Hoefler H and Becker
KF: Role of the epithelial-mesenchymal transition regulator slug in
primary human cancers. Front Biosci. 14:3035–3050. 2009. View Article : Google Scholar : PubMed/NCBI
|
8
|
Wang SP, Wang WL, Chang YL, Wu CT, Chao
YC, Kao SH, Yuan A, Lin CW, Yang SC, Chan WK, et al: p53 controls
cancer cell invasion by inducing the MDM2-mediated degradation of
Slug. Nat Cell Biol. 11:694–704. 2009. View
Article : Google Scholar : PubMed/NCBI
|
9
|
Kim J, Bae S, An S, Park JK, Kim EM, Hwang
SG, Kim WJ and Um HD: Cooperative actions of p21WAF1 and p53 induce
Slug protein degradation and suppress cell invasion. EMBO Rep.
15:1062–1068. 2014. View Article : Google Scholar : PubMed/NCBI
|
10
|
Lee JT and Gu W: The multiple levels of
regulation by p53 ubiquitination. Cell Death Differ. 17:86–92.
2010. View Article : Google Scholar : PubMed/NCBI
|
11
|
Marine JC and Lozano G: Mdm2-mediated
ubiquitylation: p53 and beyond. Cell Death Differ. 17:93–102. 2010.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Wade M, Wang YV and Wahl GM: The p53
orchestra: Mdm2 and Mdmx set the tone. Trends Cell Biol.
20:299–309. 2010. View Article : Google Scholar : PubMed/NCBI
|
13
|
Jin Y, Lee H, Zeng SX, Dai MS and Lu H:
MDM2 promotes p21waf1/cip1 proteasomal turnover independently of
ubiquitylation. EMBO J. 22:6365–6377. 2003. View Article : Google Scholar : PubMed/NCBI
|
14
|
Zhang Z, Wang H, Li M, Agrawal S, Chen X
and Zhang R: MDM2 is a negative regulator of p21WAF1/CIP1,
independent of p53. J Biol Chem. 279:16000–16006. 2004. View Article : Google Scholar : PubMed/NCBI
|
15
|
Lee J, Kim J, Kim EM, Kim U, Kang AR, Park
JK and Um HD: p21WAF1/CIP1 promotes p53 protein degradation by
facilitating p53-Wip1 and p53-Mdm2 interaction. Biochem Biophys Res
Commun. 543:23–28. 2021. View Article : Google Scholar : PubMed/NCBI
|
16
|
Bunz F, Dutriaux A, Lengauer C, Waldman T,
Zhou S, Brown JP, Sedivy JM, Kinzler KW and Vogelstein B:
Requirement for p53 and p21 to sustain G2 arrest after DNA damage.
Science. 282:1497–1501. 1998. View Article : Google Scholar : PubMed/NCBI
|
17
|
Kim EM, Jung CH, Kim J, Hwang SG, Park JK
and Um HD: The p53/p21 complex regulates cancer cell invasion and
apoptosis by targeting Bcl-2 family proteins. Cancer Res.
77:3092–3100. 2017. View Article : Google Scholar : PubMed/NCBI
|
18
|
Jung CH, Kim EM, Song JY, Park JK and Um
HD: Mitochondrial superoxide dismutase 2 mediates
γ-irradiation-induced cancer cell invasion. Exp Mol Med. 51:1–10.
2019. View Article : Google Scholar
|
19
|
Kim DK, Cho ES, Seong JK and Um HD:
Adaptive concentrations of hydrogen peroxide suppress cell death by
blocking the activation of SAPK/JNK pathway. J Cell Sci.
114:4329–4334. 2001. View Article : Google Scholar : PubMed/NCBI
|
20
|
Kim EM, Kim J and Um HD: Bcl-2 protein
targeting by the p53/p21 complex-response. Cancer Res.
78:2772–2774. 2018. View Article : Google Scholar : PubMed/NCBI
|
21
|
Zhao Y, Yu H and Hu W: The regulation of
MDM2 oncogene and its impact on human cancers. Acta Biochim Biophys
Sin (Shanghai). 46:180–189. 2014. View Article : Google Scholar : PubMed/NCBI
|
22
|
Jung CH, Kim J, Park JK, Heang SG, Moon
SK, Kim WJ and Um HD: Mdm2 increases cellular invasiveness by
binding to and stabilizing the Slug MRNA. Cancer Lett. 335:270–277.
2013. View Article : Google Scholar : PubMed/NCBI
|
23
|
Mello SS and Attardi LD: Deciphering p53
signaling in tumor suppression. Curr Opin Cell Biol. 51:65–72.
2018. View Article : Google Scholar : PubMed/NCBI
|
24
|
Manfredi JJ: The Mdm2-p53 relationship
evolves: Mdm2 swings both ways as an oncogene and a tumor
suppressor. Genes Dev. 24:1580–1599. 2010. View Article : Google Scholar : PubMed/NCBI
|
25
|
Boyd SD, Tsai KY and Jacks T: An intact
HDM2 RING-finger domain is required for nuclear exclusion of p53.
Nat Cell Biol. 2:563–568. 2000. View
Article : Google Scholar : PubMed/NCBI
|
26
|
Geyer RK, Yu ZK and Maki CG: The MDM2
RING-finger domain is required to promote p53 nuclear export. Nat
Cell Biol. 2:569–573. 2000. View
Article : Google Scholar : PubMed/NCBI
|
27
|
Kim EM, Park JK, Hwang SG, Kim WJ, Liu ZG,
Kang SW and Um HD: Nuclear and cytoplasmic p53 suppress cell
invasion by inhibiting respiratory complex-I activity via Bcl-2
family proteins. Oncotarget. 5:8452–8465. 2014. View Article : Google Scholar : PubMed/NCBI
|
28
|
Mihara M, Erster S, Zaika A, Petrenko O,
Chittenden T, Pancoska P and Moll UM: p53 has a direct apoptogenic
role at the mitochondria. Mol Cell. 11:577–590. 2003. View Article : Google Scholar : PubMed/NCBI
|
29
|
Chipuk JE, Kuwana T, Bouchier-Hayes L,
Droin NM, Newmeyer DD, Schuler M and Green DR: Direct activation of
bax by p53 mediates mitochondrial membrane permeabilization and
apoptosis. Science. 303:1010–1014. 2004. View Article : Google Scholar : PubMed/NCBI
|